Chromatin Immunoprecipitation Sequencing Market

Future Market Insights

Key Insight

The chromatin immunoprecipitation sequencing market is projected to grow from USD 1.5 billion in 2025 to USD 3.7 billion by 2035, at a CAGR of 9.3%. Chromatin Immunoprecipitation Sequencing Kits will dominate with a 60.0% market share, while cancer will lead the applications segment with a 40.0% share.

October 06, 2025

Anurag Sharma

275 Pages

Cite this Report

Chromatin Immunoprecipitation Sequencing Market

https://www.futuremarketinsights.com/reports/chromatin-immunoprecipitation-sequencing-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abcam plc
Active Motif
Bio-Rad
Bio-Techne
BioLegend
Cell Signaling Technology
Creative Diagnostics
Merck KGaA
Profacgen
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Chromatin Immunoprecipitation Sequencing Market

Key Players

Similar Industry Reports